^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) + doxorubicin hydrochloride (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Endometrial carcinoma: Other recommended regimens…cisplatin/doxorubicin
